• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MacDermid Incorporated

MacDermid Incorporated

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Plating on Plastics (POP) Market Analysis, By Plating, Plastic, Application And Segment Forecasts, 2014 - 2025 - Research and Markets

    Plating on Plastics (POP) Market Analysis, By Plating, Plastic, Application And Segment Forecasts, 2014 - 2025 - Research and Markets

  2. Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance Setting

    Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance Setting

  3. bluebird bio and Celgene Corporation Announce Updated Clinical Results from Ongoing First-in-Human Multicenter Study of bb2121 Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma at ...

    bluebird bio and Celgene Corporation Announce Updated Clinical Results from Ongoing First-in-Human Multicenter Study of bb2121 Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting

  4. Infiniti Research Highlights the Future Effects of New Medical Devices Regulations (MDR) in the European Market

    Infiniti Research Highlights the Future Effects of New Medical Devices Regulations (MDR) in the European Market

  5. Roth Conversion of Aftertax Money

    Natalie Choate answers reader questions about Roth conversion rules as they relate to inherited IRAs and profit-sharing plans.

1

©2017 Morningstar Advisor. All right reserved.